Collagen Solutions Share Discussion Threads

[mike740] 08/9/2015 15:31

WHAT!!!!!!!!!!!!!!!!!!!!!!!!you were a dead loss on MAM.

doodlebug4 - 08 Sep 2015 - 12:43:20 - 212919 of 212950
Interesting LuckyMouse. I hold six shares at the moment and COS, FLYB and INSE are three of them, so I was just giving the Barchart tool a try out of interest. I've found over the years that a mixture of following charts, checking fundamentals and gut feeling work reasonably well for me when choosing stocks - and, of course, doing my own research into some of the great shares flagged up by other posters on this thread!...................ends

[mike740] 08/9/2015 12:18

Nearly got that chart done doddles aka Tulip.

[doodlebug4] 08/9/2015 11:07

Proactive Investors One2One Investor Forum - London
Avation | Tern PLC | Versarien Plc | Collagen Solutions
Share
Sep 9th 2015, 6.00 pm - Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair

The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canapé and wine reception. Details on the presenting companies can be found below.

 

This event is suitable for the following:

Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.

 

The event is not suitable for people pursuing commercial opportunities.

[mike740] 07/9/2015 20:29

Will have a go at that chart now.

[mike740] 07/9/2015 20:29

Theres a video above but dont know how to transport it.

[mike740] 07/9/2015 20:28

here we are Doodlebug....

Collagen Solutions CEO Stewart White discusses the new Research Project
Collagen Solutions CEO Dr Stewart White chats with DirectorsTalk about being chosen to participate in a new research project to develop novel treatments for Parkinson’s disease.


Dr Stewart White was CEO of Collbio and has recent and direct board experience of an AIM quoted company. Stewart has international experience in operations, business and product development, and ‘Good Manufacturing Practices’ (GMP) compliant manufacturing of collagen medical devices, advanced biologics and Active Pharmaceutical Ingredients in both Small to Medium Enterprises as well as global pharmaceutical companies. Stewart is a graduate of the University of Strathclyde and holds a First Class degree in Applied Microbiology, a Ph.D. in Fermentation Technology and Bioprocessing and an MBA.
Collagen Solutions Plc was established and admitted to the London Stock Exchange on the 2nd January 2014 when Collbio Limited acquired the assets of Collagen Solutions LLC and went through a simultaneous reverse takeover under Rule 14 of the AIM Rules for Companies into Healthcare Investment Opportunities plc, which became Collagen Solutions Plc. On 10th December 2014, by way of reverse takeover, Collagen Solutions Plc, acquired Southern Lights Biomaterials based in New Zealand, being a logical strategic extension and complementary in nature to the Group’s existing business model.
Collagen Solutions plc provides customers with medical grade collagen products and development services to create collagen components from concept to clinical trial stage, including technology transfer and contract manufacturing.

[mike740] 07/9/2015 20:22

Ohhhhhhh and theres an interview with the boss.



Now which board did I see it on.

Ill have a look.

[mike740] 07/9/2015 20:21

Just doing the chart, these png thingys are difficult to copy, might take a few attempts but ill get it right in the end.

[mike740] 07/9/2015 20:19

Zak Mir's Bull Call Of The Day No.1: Collagen Solutions: 16p Achievable After Extended Base - See more at: hxxp://www.shareprophets.com/#sthash.EPmAjzel.dpuf

Slow but steady, is probably the best non technical description of the price action on Collagen Solutions (COS) over recent months. That said, it is probably fair to say that fans of this stock are now probably quite restless for a decent bull breakthrough, after all the consolidation which they have been treated to. This is especially the case as far as the price action has been concerned since the beginning of the year. The reason for the relative optimism is the way we have seen progress within a wide rising trend channel in place on the daily chart since March last year.

While it was disappointing that there was no immediate lasting upside through at the beginning of this year from the gap to the upside through the 200 day moving average at 9p in December, even though there was a golden cross buy signal between the 50 day and 200 day lines soon after in January. But at least the buy signal did appear to underpin the shares, something which can be seen from the February, March and June all put in decent support points above the main 8p support zone. What should now drive further gains is the way that since July both the 50 day and 200 day moving averages have been rising, something which should lead the stock higher.

The favoured scenario is for a break to the upside towards the top of the 2014 price channel at 16p over the next 1-2 months. At this stage only an end of day close back below the 50 day moving average at 11.02p would even begin to delay the upside scenario. .

- See more at: hxxp://www.shareprophets.com/views/14797/zak-mir-s-bull-call-of-the-day-no1-collagen-solutions-16p-achievable-after-extended-base#sthash.enNtVbjS.dpuf

[mike740] 07/9/2015 20:17

What I think you have to do here is check out comp from the US and japan maybe china aswel.

[mike740] 07/9/2015 20:16

hey this collagen stuff is starting to interest me. Just read a tip from Zak Mir.

[mike740] 07/9/2015 20:15

No probs then. I was trying to be reasonable. Sorry.

[doodlebug4] 07/9/2015 20:12

What part of toddle off don't you understand.

[mike740] 07/9/2015 19:30

Hmmmm

SHAME THE TIPSTERS - T1PS
doodlebug4 - 07 Sep 2015 - 17:23:50 - 3885 of 3891

mike740, since you have already said you wouldn't touch COS with a bargepole - when the share price was just over 8p in June - I would be obliged if you would stop playing your silly games and posting asinine comments on the COS thread. Thanks...
.......................ends


Me playing silly games!!! I dont think so.

If I posted here for another 2 months then perhaphs I might have caught up with your asinine comments on my FOXT thread.

And then theres the snooping on my Twitter feed, dont think for one minute im not aware of it. And of course this silly game of yours and someone from MAM trying to make out Im another handle.......what was it terries trousers or something similar.

Of course a deal can be done, thats what life is about.


So I would say you owe me 2 favours. Let me know if your interested.

[doodlebug4] 07/9/2015 17:19

Mike740, you said in June that you wouldn't touch this share with a bargepole and the share price was then just over 8p - the share price is now 12p. Since you have no interest, or understanding of this company, why don't you just toddle off my little troll and play your silly games on other threads. Thanks.

[mike740] 07/9/2015 17:05

doodlebug4 3 Sep'15 - 09:00 - 237 of 245 0 0 (Filtered)

doodlebug4 3 Sep'15 - 11:11 - 238 of 245 0 0 (Filtered)

doodlebug4 3 Sep'15 - 12:45 - 239 of 245 0 0 (Filtered)

doodlebug4 3 Sep'15 - 16:21 - 240 of 245 0 0 (Filtered)

doodlebug4 3 Sep'15 - 16:59 - 241 of 245 0 0 (Filtered)

doodlebug4 4 Sep'15 - 10:56 - 242 of 245 0 0 (Filtered)

doodlebug4 6 Sep'15 - 09:09 - 243 of 245 0 0 (Filtered)

doodlebug4 7 Sep'15 - 14:07 - 244 of 245 0 0 (Filtered)

doodlebug4 7 Sep'15 - 16:47 - 245 of 245 0 0 (Filtered)

[doodlebug4] 07/9/2015 16:47

Zac Mir;

Slow but steady, is probably the best non technical description of the price action on Collagen Solutions (COS) over recent months. That said, it is probably fair to say that fans of this stock are now probably quite restless for a decent bull breakthrough, after all the consolidation which they have been treated to. This is especially the case as far as the price action has been concerned since the beginning of the year. The reason for the relative optimism is the way we have seen progress within a wide rising trend channel in place on the daily chart since March last year.

While it was disappointing that there was no immediate lasting upside through at the beginning of this year from the gap to the upside through the 200 day moving average at 9p in December, even though there was a golden cross buy signal between the 50 day and 200 day lines soon after in January. But at least the buy signal did appear to underpin the shares, something which can be seen from the February, March and June all put in decent support points above the main 8p support zone. What should now drive further gains is the way that since July both the 50 day and 200 day moving averages have been rising, something which should lead the stock higher.

The favoured scenario is for a break to the upside towards the top of the 2014 price channel at 16p over the next 1-2 months. At this stage only an end of day close back below the 50 day moving average at 11.02p would even begin to delay the upside scenario. .

[doodlebug4] 07/9/2015 14:07

I haven't read the whole analysis, but I would think that 16p is his immediate, rather than long term target:

Zak Mir's Bull Call Of The Day No.1: Collagen Solutions: 16p Achievable After Extended Base
By Zak Mir | Monday 7 September 2015

[doodlebug4] 06/9/2015 09:09

Collagen Solutions exhibiting at the TERMIS World Congress this coming week.

The Evolution of Regenerative Medicine
The theme for the 2015 TERMIS World Congress is "Past, Present Future: The Evolution of Regenerative Medicine," reflecting the impact of tissue engineering throughout the past two decades, and focusing on the future. To this end, the 2015 scientific program will focus on the innovative technologies focused in regenerative medicine.

The TERMIS World Congress Meeting is held every three years, and brings together researchers, scientists, trainees, and students from both academia and industry to discuss critical developments in the field. The meeting is led by keynote speakers each day, and consists of parallel technical sessions as well as poster presentations. A strong role in the meeting planning and execution will be played by the TERMIS Student and Young Investigator Section (SYIS). Furthermore, there will be an emphasis on promoting the careers of women and underrepresented groups in the tissue engineering and regenerative medicine fields

[doodlebug4] 04/9/2015 10:56

Beaufort Securities update today:

Our view: Collagen Solutions is the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics. The news of NovaBone receiving an approval strengthens Collagen Solutions’ long-term partnership with its client. As a huge supplier of medical grade collagen, the company would gain from the introduction of this product. Last week, Collagen Solutions was selected to participate in a new research project aimed at developing novel new treatments for the Parkinson’s disease, headed by the Centre for Research in Medical Devices (CÚRAM). The company joining such a valued consortium validated its brand name for developing and supplying high quality products. Further, the company is paving the way for strong and long standing partnerships with its customers, including Globus Medical, by entering into several strategic arrangements at an early stage. Meanwhile, the company continues to invest in people and facilities as it expands the sales pipeline. In view of the developments surroundings Collagen Solutions, we maintain a Speculative Buy rating on the stock.

[doodlebug4] 03/9/2015 16:59

free stock charts from uk.advfn.com

[doodlebug4] 03/9/2015 16:21

Life sciences firm Collagen Solutions got a share boost today as it revealed that one of its long-term clients had gained US approval for a new device that makes collagen products easier to use.

The Glasgow-based group said NovaBone had been given the green light from the US Food & Drug Administration for a delivery system designed for “minimally invasive” orthopedic procedures.

 
MacroForm has been developed for surgeons requiring precise delivery of collagen bone grafting material to surgical sites that are not readily accessible.

The Scots firm is a key supplier of medical grade collagen to NovaBone, so is likely to benefit from the introduction of the new device.

Stewart White, chief executive of Collagen Solutions, said: “Once again, we see the long-term value generation that we can gain by having our collagen embedded into novel products.

“This impressive innovation by the team at NovaBone around making their collagen products easier to use ensures a commitment to growth of these products within attractive addressable markets.

“It is anticipated this regulatory approval for NovaBone will have a direct effect on revenues to Collagen Solutions.”

Shares in the Aim-quoted firm rose by about 8 per cent.

The Scotsman

[doodlebug4] 03/9/2015 12:45

Proactive investors have a video interview with Stewart White on their website, it's an interesting interview and worth listening to.It's not just about the company's involvement with research into Parkinson's.

[doodlebug4] 03/9/2015 11:11

Latest Beaufort Securities analysis:

Collagen Solutions (LON:COS) – Speculative Buy

On Friday, Collagen Solutions issued a press release stating it has been selected to participate in a new research project aimed at developing novel new treatments for the Parkinson’s disease. The project is titled ‘Development of Biomaterial-based Delivery Systems for Parkinson’s disease – an Integrated Pan-European Approach’, being carried with the alliance of world class researchers and industry partners. The focus of the plan is to develop a therapy that slows the progress of illness, instead of just treating the symptoms. The project is being headed by the Centre for Research in Medical Devices (CÚRAM) based in the National University of Ireland, in Galway. CÚRAM has secured €4m in funding through the European Horizon 2020 grant programme. The company being a key member of the group would receive grants to develop various types of medical grade collagens for the investigation.

Our view: The news of Collagen Solutions joining such a valued consortium validates its brand name for developing and supplying high quality products. The company’s strong Research and Development potential, global outreach and world class manufacturing facilities would help in the growth of the project. Recently, Collagen Solutions declared its first half results and reported substantial progress, along with a crucial acquisition of Southern Lights Ventures 2002 Limited. The acquired company has a strong customer base that would help in generating recurring revenues. Further, the company is paving the way for strong and long standing partnerships with its customers, including Globus Medical and Novabone, by entering into several strategic arrangements at an early stage. Meanwhile, the company continues to invest in people and facilities as it expands the sales pipeline. In view of the above argument, we maintain a Speculative Buy rating on the stock

[doodlebug4] 03/9/2015 09:00

Collagen Solutions PLC

03 September 2015

Collagen Solutions Plc

(the "Company" or the "Group")

FDA approval for NovaBone product

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that its long term client, NovaBone Products LLC (NovaBone), has had a novel device approved by the US FDA, for use in the delivery of its collagen bone graft product MacroFORM.

NovaBone has received FDA approval for the NovaBone MacroFORM MIS Delivery System designed for minimally invasive orthopedic procedures. The system was developed for surgeons requiring controlled and precise delivery of collagen bone grafting material to surgical sites that aren't readily accessible. NovaBone's MacroFORM technology allows the delivery of bone marrow aspirate and other bioactive formulations to a graft in a ready to use, minimally invasive cannula.

NovaBone has introduced six new collagen products in the last 12 months for use in the wound care and bone graft markets based on the Company's novel regenerative medicine technology and core competencies in designing innovative and cost-effective medical devices. These products use medical grade collagen supplied by Collagen Solutions plc.

Commenting on the approval Stewart White, CEO of Collagen Solutions, said: "Once again, we see the long-term value generation that we can gain by having our collagen embedded into novel products. This impressive innovation by the team at NovaBone around making their collagen products easier to use ensures a commitment to growth of these products within attractive addressable markets. It is anticipated this regulatory approval for NovaBone will have a direct effect on revenues to Collagen Solutions."

Art Wotiz, President of NovaBone Products said "We continue to reach milestones we have established. Our team has done an excellent job in terms of both design and manufacturing of collagen products and creating a robust pipeline of products that harness the natural healing process of the body."